Evidence map›Paper›PMID 28484313›Full record

ReviewActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology2016

Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.

Alberto Palladino, Paola D'Ambrosio, Andrea Antonio Papa, Roberta Petillo, Chiara Orsini, Marianna Scutifero, Gerardo Nigro, Luisa Politano

Open access · greenAbstract readReview
In one paragraph

Review in Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. TJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2020
    Article
  7. Review
  8. Duchenne and Becker muscular dystrophy in adolescents: current perspectives.Adolescent health, medicine and therapeutics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Alberto PalladinoCardiomyology and Medical Genetics, Department of Experimental Medicine.
Paola D'AmbrosioCardiomyology and Medical Genetics, Department of Experimental Medicine.
Andrea Antonio PapaCardiomyology and Medical Genetics, Department of Experimental Medicine.
Roberta PetilloCardiomyology and Medical Genetics, Department of Experimental Medicine.
Chiara OrsiniCardiomyology and Medical Genetics, Department of Experimental Medicine.
Marianna ScutiferoCardiomyology and Medical Genetics, Department of Experimental Medicine.
Gerardo NigroArrhythmologic Unit, Department of Cardiology. University of Campania "Luigi Vanvitelli", Naples, Italy.
Luisa PolitanoCardiomyology and Medical Genetics, Department of Experimental Medicine.
Czech Academy of Sciences, Institute of Experimental Medicine · CZUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscular dystrophies are a group of genetic disorders characterized by muscle degeneration and consequent substitution by fat and fibrous tissue. Cardiac involvement is an almost constant feature in a great part of these diseases, as both primary myocardial involvement and secondary involvement due to respiratory insufficiency, pulmonary hypertension or reduced mobility. Primary myocardial involvement usually begins more precociously compared to the secondary involvement. In fact the first signs of cardiomyopathy can be observed in the first decade of life in muscular dystrophies with childhood onset and later in adult form of muscular dystrophies as myotonic dystrophy type 1. At least an annual cardiac follow-up is recommended in these patients including clinical and instrumental examination (ECG, 24h Holter monitoring, ECHO), to detect cardiac involvement. A more frequent monitoring may be required according to the type of cardiomyopathy and the patient's needs. In this short review practical guide-lines are shown for physicians routinely involved in the management of these patients.

Indexed as

CardiomyopathiesDisease ManagementAdultChildHumansMuscular DystrophiesBMDcardiomyopathyDMDEDMDmuscular dystrophiesSteinert Disease

Identifiers

PMID28484313
PMCPMC5416740
OpenAlexW2971030209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.